Home Search
gene therapy - search results
If you're not happy with the results, please do another search
Study says 75% of sexual assault survivors have PTSD, one month later
The University of Washington team explain that while most sexual assault survivors have PTSD one month after the attack - it is common to feel better within three months.
Forensic treatment of young people as a chance
Insights into the forensic treatment of teenagers and adolescents at Pfalzklinikum are given here by Laura Kirschbacher.
Study finds eating disorder hospitalisations increased during pandemic
According to researchers in Michigan, eating disorder hospitalisations among adolescents increased during the COVID pandemic - as "their entire worlds were turned upside down overnight".
Volunteers are a vital part of the NHS’ past, present and future
Mark Lever, Chief Executive, Helpforce, discusses the importance of volunteers throughout the NHS’ history and for its future.
Dementia & Behavioural Symptoms of Dementia: Risk for the Latinx population
Dr Lynn Woods, Professor in the Department of Doctoral Programs, School of Nursing, Azusa Pacific University, explores behavioural symptoms of dementia in the Latinx population.
Study reveals 94% of cancer patients react well to COVID vaccine
According to the US and Swiss study, 94% of cancer patients took the COVID vaccine in full and produced antibodies - while seven high-risk patients failed to produce an immune response.
Treating vision-related conditions
Professor Heather Sheardown from McMaster University provides detail about treating vision-related conditions, including injectable, in situ gelling systems.
Reconstructive Dentistry focus
In this interview, Mutlu Özcan, Prof Dr Dr hc, PhD from University of Zürich, lavishes us with details about Reconstructive Dentistry.
CBD oil for pain: What the research shows
Oils by Simpson of 2012 supplies organic full-spectrum CBD cannabis oil products. CBD oil is popular and commonly used for its potent therapeutic benefits, but what about its effect on pain? Here’s what the research shows.
The need for improved access to epilepsy surgery
Arun Swaminathan MD, Assistant Professor of Neurology and Epilepsy at the University of Nebraska Med Ctr, explores the need for improved access to epilepsy surgery.
Could technology actually be good for our mental health?
Brendan Street, Professional Head of Emotional Wellbeing, Nuffield Health, explores whether technology can have a positive effect on our mental health.
Scientists think protein injection could be diabetes vaccine
The idea is still at an early stage, but initial clinical study results show that immunotherapy against type 1 diabetes could function as a 'diabetes vaccine.'
Building readiness for innovative health technologies
Senior Researcher in Social Science Michael Morrison explains why disruptive technologies need institutional and systemic readiness to truly realise the benefits of healthcare innovation.
How patients can overcome needle phobia and get the COVID vaccine
Dr Deborah Lee, Dr Fox Online Pharmacy, explores what can be done to help patients who refuse the COVID-19 vaccination due to needle phobia.
Life expectancy is up for HIV patients in Latin America
Researchers studied over 30,688 HIV patients across seven Latin American countries - finding that life expectancy has dramatically increased over a period of 14 years.
Trial finds York/Hull leishmaniasis vaccine is safe
A new vaccine, developed by researchers at the Hull York Medical School, to treat leishmaniasis has proved to be safe in the first clinical trials.
CBD oil for ADHD: What the research shows
CBD oil is popular for its wide-ranging therapeutic benefits, but what about its effects on ADHD? Here’s what the research shows.
Improving cancer treatment and services during and beyond COVID-19
Greg Quinn, BD UK, explores how cancer treatment and services have been impacted by the pandemic and the potential role of medical technology in supporting the NHS during this complex time.
Biosimilars: Improve access to treatment & reduce cost
Tore K Kvien & Guro L Goll argue that biosimilars are an opportunity for improving access to treatment & reducing cost and provide comment on the NOR-SWITCH study.
Brain cancer therapeutics: Overcoming the barriers
Sean E. Lawler PhD from Brigham and Women’s Hospital, Harvard Medical School, sheds light on overcoming the barriers when it comes to brain cancer therapeutics.